Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Antiparasitics

EPRUMA unveils guidance for anthelmintic use in food-producing animals

The European Platform for the Responsible Use of Medicines in Animals (EPRUMA) has launched a new publication to tackle anthelmintic resistance.

Policy & Regulation Antiparasitics

Zoetis to market Revolution Plus in 2019, eyes more lifecycle innovation

Zoetis is to add to its Revolution (selamectin) canine parasiticide brand next year, by bringing a new product to market in the US.

Zoetis R&D

Boehringer assesses options as LongRange again receives CVMP negative opinion

European authorities have again recommended Boehringer Ingelheim's Longrange 50 mg/ml (eprinomectin) should not be approved.

Boehringer Ingelheim Animal Health Antiparasitics

Scientists discuss research, strategies against anthelmintic resistance

A group of 90 researchers from 30 countries have gathered to share research and discuss coordinating an approach to developing solutions for anthelmintic resistance. 

Research Antiparasitics

American Vanguard to save TyraTech from 'fragile financial situation' with purchase

US agricultural products business American Vanguard (AMVAC) is to acquire the shares in TyraTech that it did not already own.

M&A Antiparasitics

FDA warns of adverse drug events related to isoxazolines

The US FDA is alerting pet owners and veterinarians of the possible adverse neurological events to cats and dogs associated with isoxazoline flea and tick products.

FDA Antiparasitics

New Kansas City company to provide market with revenue-ready products

Covenant Animal Health Partners has been launched to focus on bringing animal health innovations to market.

R&D Companion Animals

Bayer's Seresto collar approved for reducing leishmaniasis transmission

Bayer Animal Health's Seresto flea and tick collar has recently been licensed in several European countries to reduce the risk of canine leishmaniasis.

Europe Bayer Animal Health

Piedmont, Norbrook gain generic approvals for pets and livestock

Piedmont Animal Health and Norbrook Laboratories are among several firms to have gained recent product approvals from the US FDA.

United States Bayer Animal Health

Zoetis seeks 2020 launch for Simparica Trio

Zoetis is aiming to get approval for a new three-way combination parasiticide, with launches penciled in for 2020.

Antiparasitics Zoetis

Zoetis to discontinue sales of equine wormer

Zoetis' Equitape praziquantel-only wormer for horses will be discontinued from the firm's equine product range in October 2018.

United Kingdom Antiparasitics

Boehringer extends Nexgard indications with new approval

Boehringer Ingelheim Animal Health's NexGard antiparasitic chewable tablet for dogs has gained a supplemental approval from the US FDA for the prevention of a bacterial infection.

Boehringer Ingelheim Animal Health Product Approvals
See All